Saimu Bioworks accelerates discovery for AI-driven biotech startups and big pharma — from target identification to clinical pipeline optimization.
What we do
We bridge the gap between AI-driven hypotheses and wet-lab validation, so your pipeline moves faster and smarter.
AI-assisted identification and biological validation of novel drug targets across oncology, rare disease, and CNS.
Custom assay pipelines optimized for your AI model outputs — from HTS to phenotypic screening and functional readouts.
High-quality, ML-ready biological datasets to train, fine-tune, and validate your AI models with confidence.
Integrated CRO support and scientific project management to compress your preclinical timelines without compromising rigor.
Scientific advisory and IND-enabling support to bridge your AI-predicted candidates to clinical-stage readiness.
Bridging computational predictions with experimental reality — we help your models learn from biology, not just predict it.
Our team
A cross-disciplinary team of biologists, data scientists, and translational researchers united by one goal — faster, smarter drug discovery.
Former Eli Lilly Company Gene Editing Senior Advisor.
Former Charles River Project Manager and Scientist.
Scientific Advisory Board
Our scientific advisory board brings deep domain knowledge across genomics, drug discovery, translational medicine, and AI-driven biology.
CEO, Aridica. Ph.D. Deep expertise in biotech leadership and innovation.
LinkedInChief Development Officer, Stealth Biotech. Former VP, Takeda.
LinkedInFounder, biomedzglobal.com. CEO, PCOSDiva.com. Editor, Kidney Cancer Journal. 25 years in oncology & pharmacovigilance.
LinkedInFounder & CSO, MuriPhys LLC. Based in Durham, North Carolina.
LinkedInTestimonials
Trusted by leading AI biotech teams pushing the frontier of data-driven medicine.
Saimu Bioworks cut our target validation cycle from 6 months to under 8 weeks. Their team truly understands what AI-first drug discovery needs from the wet lab.
The data quality is exceptional — structured exactly for ML training. We fed their datasets directly into our foundation model and saw a 40% improvement in hit rate.
As a big pharma team integrating AI tools, we needed a partner who could translate model outputs into real experimental designs. Saimu does exactly that — brilliantly.
Why us
We're not a traditional CRO. We're a scientific partner who deeply understands AI-driven biology — and what it takes to make predictions real.
Our team has worked inside AI biotech companies — we understand your models, your data needs, and your timelines from the inside out.
We seamlessly connect computational predictions to experimental validation, so nothing gets lost in translation between your AI team and the bench.
Our integrated workflows compress timelines by 3× on average — not by cutting corners, but by eliminating the coordination friction that slows most CROs down.
Every dataset we generate is structured, annotated, and formatted for direct model ingestion — no cleanup, no reformatting, no delays.
Whether you need a single assay or an end-to-end preclinical program, we scale to your project — not the other way around.
From seed-stage AI biotechs to global pharma R&D divisions, our partners trust us with their most critical discovery programs.
Get in touch
Tell us about your project and we'll be in touch within 24 hours.
Address:
Saimu Bioworks Pvt Ltd
801 Capitola Drive, Ste. 12 Durham NC 27713
Email:
info@saimubioworks.com
Phone:
+1 774 232 3001
Working Hours:
Monday – Friday
9:00 AM – 6:00 PM